Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ultrasound may make blood draws safer and faster for shock patients

NCT ID NCT07362628

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether using ultrasound to guide a needle into the wrist artery works better than the usual method of feeling for the pulse in emergency patients with shock. One hundred adults were randomly assigned to either ultrasound guidance or the traditional palpation technique. The researchers measured how often the first attempt succeeded, how many tries were needed, and the time to get a blood sample.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If ultrasound proves better, it could become the standard method for arterial blood draws in shock patients, making the procedure faster and more successful.
What could go wrong
This is a small, completed study (100 patients) comparing two techniques. Results may not apply to all settings or patient groups, and ultrasound requires extra equipment and training.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

100 people

The number who actually took part.

Started

Oct 2024

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 years and older * Patients diagnosed with shock * Patients with an indication for arterial blood gas analysis due to respiratory or metabolic disorders * Patients who provided written informed consent, either personally or through their legal representatives. Exclusion Criteria: * Patients who declined to participate * Patients presenting with cardiac arrest * Patients with a positive Allen test * Patients with a history of coagulopathy * Patients with evidence of infection at the puncture site * Patients with evidence of trauma at the puncture site * Patients with an arteriovenous fistula at the puncture site

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Shock are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cardiogenic shock Emergencies Shock

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Alanya Alaaddin Keykubat University Hospital

    Alanya, Antalya, 07400, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.